Treatment with several GnRHR2 antagonists inhibited growth of human endometrial and ovarian cancer cells in vitro and in vivo via caspase 3-dependent mechanisms (175); a different GnRHR2 antagonist (SN09-2) induced apoptosis in prostate cancer cells (172). Here, GNRHR2 is linked to ovarian cancer.